Apparatus and method for transdermal delivery of parathyroid hormone agents
First Claim
Patent Images
1. A device for transdermally delivering a PTH-based agent to a patient, comprising:
- a microprojection member having a plurality of microprojections that are adapted to pierce the stratum corneum of the patient; and
a biocompatible coating disposed on said microprojection member, said coating comprising a hPTH acetate, hydrochloric acid, Tween, sucrose, and EDTA.
3 Assignments
0 Petitions
Accused Products
Abstract
An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
146 Citations
2 Claims
-
1. A device for transdermally delivering a PTH-based agent to a patient, comprising:
-
a microprojection member having a plurality of microprojections that are adapted to pierce the stratum corneum of the patient; and a biocompatible coating disposed on said microprojection member, said coating comprising a hPTH acetate, hydrochloric acid, Tween, sucrose, and EDTA.
-
-
2. A device for transdermally delivering a PTH-based agent to a patient, comprising:
-
a microprojection member having a plurality of microprojections that are adapted to pierce the stratum corneum of the patient; and a biocompatible coating disposed on said microprojection member, said coating being formed from a coating formulation comprising 20% hPTH(1-34) or salts thereof, 20% sucrose, 0.6% HCl, 0.2% Tween 20, and 0.03% EDTA and is at a dose of approximately 10-1000 μ
g that results in a plasma Cmax of at least 50 pg/ml after a single application.
-
Specification